McDermott Advises DBV Technologies on its Global Collaboration with Nestlé Health Science - McDermott Will & Emery

McDermott Advises DBV Technologies on its Global Collaboration with Nestlé Health Science

Overview


PARIS (June 9, 2016) –International law firm McDermott Will & Emery advised biopharmaceutical company DBV Technologies on its global collaboration agreement with Nestlé Health Science to develop and commercialize MAG1C, an innovative patch-test for the diagnosis of Cow’s Milk allergy (CMPA) in infants and toddlers. The new diagnostic test is expected to be submitted for approval to regulatory authorities worldwide by 2021.

Under the terms of the agreement, which closed on 1 June 2016, DBV will be eligible to receive up to €100 million in development, registration and commercial milestones, including an upfront payment of €10 million. DBV will be responsible for performing development activities through a pivotal clinical program, following which Nestlé Health Science has the exclusive right to commercialize the product globally.

The McDermott team led was by Paris-based partners Emmanuelle Trombe and Anthony Paronneau and included partner Sarah Hogan and associate Christine Wahr from the Firm’s Boston office.

McDermott’s Life Sciences Group works with clients to structure collaborative arrangements among emerging life sciences companies, established pharmaceutical and biotech companies and researchers and research institutions. These arrangements range from licensing technology to and from academic medical centres, universities and other research institutions, to complex strategic alliances among life sciences companies to achieve varied financial, research and development, manufacturing and distribution objectives. The Firm’s long-term experience in advising pharmaceuticals and agrochemical companies on taxation issues allows us to devise structures and tax plans for life sciences companies who wish to be attractive partners or acquisition candidates for the pharmaceutical industry.

About McDermott


McDermott Will & Emery is a premier international law firm with a diversified business practice. Numbering more than 1,000 lawyers, we have offices in Boston, Brussels, Chicago, Dallas, Düsseldorf, Frankfurt, Houston, London, Los Angeles, Miami, Milan, Munich, New York, Orange County, Paris, Rome, Seoul, Silicon Valley and Washington, D.C. Further extending our reach into Asia, we have a strategic alliance with MWE China Law Offices in Shanghai.